Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Shrirang V. Ranade"'
Autor:
Nancy M. Holekamp, Manejeh Yaqub, Shrirang V. Ranade, Ronald A. Cantrell, Sheena Singh, Gus Gazzard
Publikováno v:
Ophthalmology and Therapy, Vol 13, Iss 9, Pp 2303-2329 (2024)
Abstract Objectives To determine whether the types and rates of post-surgical complications associated with the Port Delivery System with ranibizumab (PDS) are comparable with those reported for other ocular implants that cross the sclera. Methods Sy
Externí odkaz:
https://doaj.org/article/63a3efc1f3b54d1a99c2b0af0745d82f
Autor:
Shrirang V. Ranade, Mark R. Wieland, Tammy Tam, Jennifer C. Rea, Judit Horvath, Aaron R. Hieb, Weitao Jia, Lori Grace, Giulio Barteselli, Jay M. Stewart
Publikováno v:
Drug Delivery, Vol 29, Iss 1, Pp 1326-1334 (2022)
The Port Delivery System with ranibizumab (PDS) is an innovative intraocular drug delivery system designed for the continuous delivery of ranibizumab into the vitreous for 6 months and beyond. The PDS includes an ocular implant, a customized formulat
Externí odkaz:
https://doaj.org/article/28e8950e7cf747c48df86516bf005aaa
Autor:
Shrirang V. Ranade, Andreas Dingeldey, Hendrik Hochstetter, Alexander Rothkegel, Felix Heimann, Giulio Barteselli, Michael Schneider, Clemens Wagner, André Brand, Laszlo Godard, Joshua Horvath
Publikováno v:
Advances in Simulation, Vol 6, Iss 1, Pp 1-7 (2021)
Advances in Simulation
Advances in Simulation
We present a summary of the development and clinical use of two custom designed high-fidelity virtual-reality simulator training platforms. This simulator development program began in 2016 to support the phase III clinical trial Archway (ClinicalTria
Autor:
Peter A. Campochiaro, Carl D. Regillo, Christopher Brittain, all Archway Investigators, Daniel M. Miller, Katie F. Maass, Margaret A Chang, Anthony P. Adamis, Erica Evans, Derrick Kaufman, Giulio Barteselli, Nancy M. Holekamp, Shienal Patel, Dante J. Pieramici, Natasha Singh, Shrirang V. Ranade
Publikováno v:
Ophthalmology. 129(3)
Purpose To evaluate the safety and efficacy of the Port Delivery System with ranibizumab (PDS) for the treatment of neovascular age-related macular degeneration (nAMD). Design Phase 3, open-label, randomized, visual acuity assessor–masked noninferi
Autor:
Helen Booler, Mauricio Maia, Chris Schuetz, Daniela Bumbaca Yadav, Vladimir Bantseev, Shrirang V. Ranade, Amy L. Shelton, Joshua Horvath, Giulio Barteselli
Publikováno v:
Toxicologic pathology. 49(3)
The Port Delivery System with ranibizumab (PDS) is an investigational drug delivery system designed to provide continuous intravitreal release of ranibizumab for extended durations. The PDS consists of a permanent, surgically placed, refillable intra
Publikováno v:
Translational Vision Science & Technology
The Port Delivery System with ranibizumab (PDS) is an innovative, investigational drug delivery system designed for continuous delivery of ranibizumab into the vitreous to maintain therapeutic drug concentrations for extended durations. The phase 2 L
Autor:
Shrirang V. Ranade, Kishore Udipi
Publikováno v:
Medical Coatings and Deposition Technologies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef35adb3cfe4f2d763980fe2f8f7aeeb
https://doi.org/10.1002/9781119308713.ch3
https://doi.org/10.1002/9781119308713.ch3
Autor:
Lori Alquier, Shrirang V. Ranade
Publikováno v:
Medical Coatings and Deposition Technologies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::919fd66fa0c89ec5d56a516060c09fbe
https://doi.org/10.1002/9781119308713.ch21
https://doi.org/10.1002/9781119308713.ch21
Autor:
David A. Glocker, Shrirang V. Ranade
Publikováno v:
Medical Coatings and Deposition Technologies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e3367ccc7171893e8aa820767dc4b03
https://doi.org/10.1002/9781119308713.ch23
https://doi.org/10.1002/9781119308713.ch23
Publikováno v:
Acta Biomaterialia. 1:137-144
The use of styrenic block copolymers has undergone a renaissance as a biomaterial and drug delivery matrix. The early promise posed by the physical and biological properties of these block copolymers for implantable medical devices was not met. Howev